Nonseminomatous testicular cancer.
Testicular cancer is the most common solid malignancy in young men between the ages of 20 and 40 years. Its incidence is increasing worldwide. The success achieved in its treatment has not been seen in any other cancer. This communication will present some of the controversies in the management of nonseminomatous germ cell tumors, the changes that were introduced over the last two decades to decrease the toxicity from treatment and will discuss the most up-to-date treatment of every clinical stage of the disease.
Freiha
Fuad
F
Department of Urology, Stanford University School of Medicine, USA. elfou@yahoo.com
D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000628:therapy*; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*
D014408:Biomarkers, Tumor